Table 4.

Univariate Predictors

	Willing	Not Willing	P Value
Univariate analysis, factors associated with willingness to take celecoxib
Baseline	15%	85%
Age (mean)	65.2	64.4	0.81
Gender
Male	15% (11/72)	85% (61/72)	1.0
Female	14% (4/28)	86% (24/28)
Current/prior COX-2
Yes	11% (3/27)	89% (24/27)	0.75
No	16% (12/73)	84% (61/73)
Hx cancer
Yes	6% (1/16)	94% (15/16)	0.45
No	17% (14/84)	83% (70/84)
Hx heart disease
Yes	14% (4/28)	86% (24/28)	1.0
No	15% (11/72)	85% (61/72)
Barrett’s dysplasia
Yes	18% (9/50)	82% (41/50)	0.40
No	12% (6/50)	88% (44/50)
Education level
Less than HS	20% (1/5)	80% (4/5)	0.45
HS or GED	19% (5/26)	81% (21/26)
College	9% (4/43)	91% (39/43)
Postgraduate	19% (5/26)	81% (21/26)
Univariate analysis, factors associated with willingness to take ASA
Baseline	76%	24%
Age (mean)	62.9	69.8	0.009
Gender
Male	74% (53/72)	27% (19/72)	0.37
Female	82% (23/28)	18% (5/28)
Current ASA use
Yes	69% (27/39)	31% (12/39)	0.21
No	80% (49/61)	20% (12/61)
Hx cancer
Yes	63% (10/16)	38% (6/16)	0.20
No	79% (66/84)	21% (18/84)
Hx heart disease
Yes	64% (18/28)	36% (10/28)	0.09
No	81% (58/72)	19% (14/72)
Barrett’s dysplasia
Yes	70% (35/50)	30% (15/50)	0.16
No	82% (41/50)	18% (9/50)
Education level
Less than HS	20% (1/5)	80% (4/5)	0.01
HS or GED	69% (18/26)	31% (8/26)
College	86% (37/43)	14% (6/43)
Postgraduate	77% (20/26)	23% (6/26)

ASA = aspirin; Hx = history; HS = high school; GED = graduate equivalency diploma.

Percentages do not always add to 100% because of rounding.